Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -2.41%6.19B | -2.03%3.9B | -3.23%1.87B | -1.82%8.36B | -3.29%6.34B | -0.71%3.98B | 6.52%1.94B | 67.80%8.51B | 75.07%6.56B | 86.26%4.01B |
| Cash received relating to other operating activities | 13.98%1.92B | 36.55%1.2B | 284.74%656.69M | 347.61%2.22B | 341.29%1.68B | 198.10%878.51M | -5.03%170.69M | 146.91%495.85M | 92.59%381.45M | 96.79%294.7M |
| Cash inflows from operating activities | 1.03%8.11B | 4.95%5.1B | 20.09%2.53B | 17.41%10.58B | 15.65%8.02B | 12.90%4.86B | 5.49%2.11B | 70.81%9.01B | 75.95%6.94B | 86.94%4.3B |
| Goods services cash paid | -7.02%1.48B | -7.05%952.5M | -14.86%413.2M | -1.66%2.06B | 7.87%1.6B | 8.81%1.02B | 37.98%485.32M | 48.37%2.09B | 42.15%1.48B | 55.74%941.82M |
| Staff behalf paid | 1.20%1.74B | 0.15%1.2B | -4.29%663.6M | 5.92%2.32B | 11.86%1.72B | 19.91%1.2B | 37.06%693.37M | 20.55%2.19B | 12.87%1.54B | 5.83%1B |
| All taxes paid | -3.26%388.27M | -15.00%250.38M | -13.57%137.4M | 23.00%536.53M | 32.33%401.33M | 45.94%294.58M | 80.64%158.98M | 55.89%436.19M | 43.67%303.28M | 38.54%201.86M |
| Cash paid relating to other operating activities | 15.91%1.87B | 35.40%1.15B | 269.80%643.75M | 730.10%2.29B | 565.24%1.61B | 409.82%848.26M | 14.70%174.08M | -2.78%276.11M | 10.23%241.99M | 16.66%166.38M |
| Cash outflows from operating activities | 2.85%5.48B | 5.51%3.55B | 22.90%1.86B | 44.26%7.21B | 49.56%5.32B | 45.73%3.37B | 37.76%1.51B | 31.77%5B | 25.72%3.56B | 25.67%2.31B |
| Net cash flows from operating activities | -2.56%2.63B | 3.67%1.55B | 12.95%673.44M | -16.02%3.37B | -20.08%2.7B | -25.17%1.49B | -33.82%596.24M | 170.62%4.01B | 203.93%3.38B | 330.07%1.99B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --16.88M | --15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | 73.36%25.28M | 4.80%15.28M | --10M | 205.52%14.59M | 205.52%14.59M | 205.52%14.59M | ---- | -84.11%4.77M | -80.94%4.77M | -68.26%4.77M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -52.38%8.25M | -40.51%7.74M | 85.70%4.98M | -32.13%31.12M | -16.03%17.32M | 4.39%13.01M | 12.82%2.68M | 453.14%45.85M | -9.77%20.63M | -11.37%12.47M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | 118.96%2.88B | 136.08%2.38B | 93.47%946.29M | -43.10%2.29B | -56.01%1.31B | -49.81%1.01B | -67.66%489.12M | 34.26%4.02B | 42.42%2.99B | 55.78%2.01B |
| Cash inflows from investing activities | 117.52%2.93B | 133.46%2.42B | 98.51%976.26M | -42.68%2.33B | -55.32%1.35B | -48.88%1.03B | -67.53%491.8M | 34.00%4.07B | 40.39%3.01B | 53.59%2.02B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -20.95%335.21M | -22.34%225M | -14.64%169.68M | -10.93%564.43M | -10.94%424.06M | -12.84%289.72M | 1.14%198.78M | -3.22%633.68M | -5.29%476.16M | -6.30%332.41M |
| Cash paid to acquire investments | 2,405.46%293.4M | 2,921.50%293.4M | ---- | 0.52%14.41M | --11.71M | --9.71M | ---- | -38.09%14.34M | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,543.88%230.14M | 10,448.21%219.96M |
| Cash paid relating to other investing activities | 76.04%3.09B | 180.48%1.98B | 263.64%960M | -33.89%2.74B | -35.31%1.76B | -61.72%707.6M | -79.25%264M | -3.16%4.15B | -23.84%2.72B | -35.84%1.85B |
| Cash outflows from investing activities | 69.72%3.72B | 148.56%2.5B | 144.11%1.13B | -30.76%3.32B | -35.93%2.19B | -58.05%1.01B | -68.49%462.78M | -3.56%4.8B | -16.36%3.42B | -25.86%2.4B |
| Net cash flows from investing activities | 6.22%-794.25M | -413.08%-87.11M | -628.59%-153.42M | -35.91%-989.41M | -106.60%-846.97M | 107.39%27.83M | -37.05%29.02M | 62.42%-727.97M | 78.94%-409.95M | 80.39%-376.54M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 4,233.75%17.34M | --20.94M | --15.6M | --4.4M | -95.94%400K | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 4,233.75%17.34M | --20.94M | --15.6M | --4.4M | -95.94%400K | ---- | ---- |
| Cash from bonds issue | ---- | ---- | ---- | 50.00%600M | 50.00%600M | --300M | ---- | -69.22%400M | -55.55%400M | ---- |
| Cash from borrowing | -24.56%328.53M | -69.07%128.53M | ---- | 18.06%449.11M | 20.98%435.51M | 15.42%415.51M | -41.67%210M | -78.31%380.4M | -65.19%360M | -55.45%360M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -21.84%38.3M | -30.00%34.3M | -30.00%34.3M |
| Cash inflows from financing activities | -68.90%328.53M | -82.42%128.53M | ---- | 30.20%1.07B | 33.00%1.06B | 85.42%731.11M | -41.10%214.4M | -73.68%819.1M | -60.08%794.3M | -77.58%394.3M |
| Borrowing repayment | -54.22%431M | -24.43%310.5M | -3.67%10.5M | -32.90%1.14B | -43.98%941.4M | -34.77%410.9M | -96.49%10.9M | -45.16%1.7B | -17.69%1.68B | -57.75%629.88M |
| Dividend interest payment | 12.76%637.91M | 27.20%563.59M | -22.54%79.86M | 58.87%669M | 75.97%565.72M | 111.02%443.07M | -18.14%103.09M | -8.66%421.1M | -0.30%321.49M | 18.32%209.97M |
| -Including:Cash payments for dividends or profit to minority shareholders | -61.34%400.08K | -54.49%400.08K | ---- | 5,373.98%45.63M | 24.15%1.03M | 113,524.57%879.2K | ---- | -95.86%833.61K | 272.95%833.61K | -99.65%773.78 |
| Cash payments relating to other financing activities | -8.14%1.11B | -2.21%735.57M | 6.21%333.58M | -15.51%1.52B | 0.46%1.21B | -7.12%752.19M | -26.60%314.08M | 44.30%1.8B | 63.29%1.2B | 94.27%809.9M |
| Cash outflows from financing activities | -19.76%2.18B | 0.22%1.61B | -0.97%423.94M | -15.07%3.33B | -15.26%2.72B | -2.64%1.61B | -50.47%428.07M | -18.42%3.93B | 3.37%3.21B | -20.89%1.65B |
| Net cash flows from financing activities | -11.53%-1.85B | -69.26%-1.48B | -98.40%-423.94M | 27.00%-2.27B | 31.16%-1.66B | 30.30%-875.05M | 57.29%-213.67M | -82.70%-3.11B | -116.97%-2.41B | -284.04%-1.26B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 278.82%625.06K | 241.17%832.29K | 1,910.65%712.96K | 120.63%423.34K | 25.90%-349.55K | -81.41%243.95K | 104.34%35.46K | -95.37%191.88K | -109.13%-471.74K | -46.56%1.31M |
| Net increase in cash and cash equivalents | -107.24%-13.96M | -103.24%-20.92M | -76.48%96.8M | -36.42%113.9M | -65.38%192.66M | 77.71%644.81M | -7.69%411.62M | 108.33%179.16M | 128.67%556.49M | 120.37%362.83M |
| Add:Begin period cash and cash equivalents | 9.62%1.3B | 9.62%1.3B | 9.62%1.3B | 17.83%1.18B | 17.83%1.18B | 17.83%1.18B | 17.83%1.18B | -68.15%1B | -68.15%1B | -68.15%1B |
| End period cash equivalent | -6.73%1.28B | -30.17%1.28B | -12.59%1.39B | 9.62%1.3B | -11.83%1.38B | 33.72%1.83B | 9.99%1.6B | 17.83%1.18B | 28.55%1.56B | -0.50%1.37B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.